No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / economics
-
Antineoplastic Agents, Immunological / economics
-
Drug Costs / legislation & jurisprudence*
-
France
-
Health Services Accessibility / legislation & jurisprudence*
-
Humans
-
Immunotherapy / legislation & jurisprudence*
-
National Health Programs / economics
-
National Health Programs / legislation & jurisprudence
-
Neoplasms / drug therapy*
-
Nivolumab / economics
-
Reimbursement Mechanisms / legislation & jurisprudence*
-
Societies, Medical
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Nivolumab
-
pembrolizumab